FDA limits use of Stryker brain stent
The US Food and Drug Administration said Wednesday it has limited the use of a Stryker Corp. brain stent used to open narrowed arteries in some patients who have had repeated strokes.
Boston Scientific Corp. said it gained US approval for a new version of its drug-coated heart stent, a product the company will manufacture itself rather than licensing from a competitor.